Filter
1653
Text search:
national
drug
authority
Featured
131
542
Language
Document type
974
240
225
95
66
20
18
8
2
2
1
1
Countries / Regions
99
80
71
67
49
47
44
44
42
42
36
35
34
33
32
31
26
24
24
22
19
18
18
17
15
13
12
10
9
9
9
8
8
8
7
6
6
6
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
847
87
67
64
48
30
24
Toolboxes
132
119
107
106
63
62
38
35
27
26
26
23
23
23
20
19
19
16
10
9
9
8
8
7
2
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
First edition, November 1997 | Revised July 2002
A survey of prevention, testing and treatment policies and practices
Malawi Health Sector Strategic Plan 2011 - 2016
recommended
Moving towards equity and quality
